secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001641172-25-023607
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel Q2 net loss $1.3M; cash $4.3M; share exchange with FITTERS on track
----------------------------------------------------------------------------

- Net loss of $1.3M (incl. $7K stock comp) vs $3.3M in Q2 2024; revenue not reported.
- Cash and equivalents $4.3M at June 30, 2025, estimated to fund into Q4 2025.
- R&D expenses dropped to $0.1M from $2.0M after UK subsidiary liquidation in Jan 2025.
- Agreed share exchange: FITTERS will exchange 100% of FITTERS Sdn. Bhd. for ~19.99% of CYCC common stock; $1M cash added; special meeting Sep 4, 2025.
- In July, one-for-15 reverse stock split to meet Nasdaq bid price; $3M Series F convertible preferred raised in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225023607/0001641172-25-023607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225023607/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-023607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer